MAGGIO, ROBERTO Statistiche
MAGGIO, ROBERTO
A 5-Year Study of Lithium and Valproic Acid Drug Monitoring in Patients with Bipolar Disorders in an Italian Clinical Center
2022-01-01 Carli, Marco; Risaliti, Eleonora; Francomano, Mena; Kolachalam, Shivakumar; Longoni, Biancamaria; Bocci, Guido; Maggio, Roberto; Scarselli, Marco
GPCRs in Intracellular Compartments: New Targets for Drug Discovery
2022-01-01 Fasciani, Irene; Carli, Marco; Petragnano, Francesco; Colaianni, Francesco; Aloisi, Gabriella; Maggio, Roberto; Scarselli, Marco; Rossi, Mario
Interaction of the preferential D3 agonist (+)PHNO with dopamine D3-D2 receptor heterodimers and diverse classes of monoamine receptor: relevance for PET imaging
2022-01-01 Petragnano, Francesco; Fasciani, Irene; Mannoury la Cour, Clotilde; di Cara, Benjamin; Aloisi, Gabriella; Carli, Marco; Kolachalam, Shivakumar; Rossi, Mario; Marampon, Francesco; Scarselli, Marco; Millan, Mark J; Maggio, Roberto
A New Threat to Dopamine Neurons: The Downside of Artificial Light
2020-01-01 Fasciani, I.; Petragnano, F.; Aloisi, G.; Marampon, F.; Rossi, M.; Coppolino, M. F.; Rossi, R.; Longoni, B.; Scarselli, M.; Maggio, R.
Molecular targets of atypical antipsychotics: From mechanism of action to clinical differences
2018-01-01 Aringhieri, Stefano; Carli, Marco; Kolachalam, Shivakumar; Verdesca, Valeria; Cini, Enrico; Rossi, Mario; Mccormick, Peter J.; Corsini, Giovanni U.; Maggio, Roberto; Scarselli, Marco
Historical Perspectives: From Monomers to Dimers and Beyond, an Exciting Journey in the World of G Protein-Coupled Receptors
2017-01-01 Rossi, Mario; Maggio, Roberto; Fasciani, Irene; Scarselli, Marco
The First Negative Allosteric Modulator for Dopamine D2 and D3 Receptors SB269652 May Lead to a New Generation of Antipsychotic Drugs
2017-01-01 Rossi, Mario; Fasciani, Irene; Marampon, Francesco; Maggio, Roberto; Scarselli, Marco
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A 5-Year Study of Lithium and Valproic Acid Drug Monitoring in Patients with Bipolar Disorders in an Italian Clinical Center | 1-gen-2022 | Carli, Marco; Risaliti, Eleonora; Francomano, Mena; Kolachalam, Shivakumar; Longoni, Biancamaria; Bocci, Guido; Maggio, Roberto; Scarselli, Marco | |
| GPCRs in Intracellular Compartments: New Targets for Drug Discovery | 1-gen-2022 | Fasciani, Irene; Carli, Marco; Petragnano, Francesco; Colaianni, Francesco; Aloisi, Gabriella; Maggio, Roberto; Scarselli, Marco; Rossi, Mario | |
| Interaction of the preferential D3 agonist (+)PHNO with dopamine D3-D2 receptor heterodimers and diverse classes of monoamine receptor: relevance for PET imaging | 1-gen-2022 | Petragnano, Francesco; Fasciani, Irene; Mannoury la Cour, Clotilde; di Cara, Benjamin; Aloisi, Gabriella; Carli, Marco; Kolachalam, Shivakumar; Rossi, Mario; Marampon, Francesco; Scarselli, Marco; Millan, Mark J; Maggio, Roberto | |
| A New Threat to Dopamine Neurons: The Downside of Artificial Light | 1-gen-2020 | Fasciani, I.; Petragnano, F.; Aloisi, G.; Marampon, F.; Rossi, M.; Coppolino, M. F.; Rossi, R.; Longoni, B.; Scarselli, M.; Maggio, R. | |
| Molecular targets of atypical antipsychotics: From mechanism of action to clinical differences | 1-gen-2018 | Aringhieri, Stefano; Carli, Marco; Kolachalam, Shivakumar; Verdesca, Valeria; Cini, Enrico; Rossi, Mario; Mccormick, Peter J.; Corsini, Giovanni U.; Maggio, Roberto; Scarselli, Marco | |
| Historical Perspectives: From Monomers to Dimers and Beyond, an Exciting Journey in the World of G Protein-Coupled Receptors | 1-gen-2017 | Rossi, Mario; Maggio, Roberto; Fasciani, Irene; Scarselli, Marco | |
| The First Negative Allosteric Modulator for Dopamine D2 and D3 Receptors SB269652 May Lead to a New Generation of Antipsychotic Drugs | 1-gen-2017 | Rossi, Mario; Fasciani, Irene; Marampon, Francesco; Maggio, Roberto; Scarselli, Marco |